Itaru Kato

41PUBLICATIONS
155CO-AUTHORS
Molecular targetsGenomicsCardiovascular medicine and haematology not elsewhere classifiedMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Jul 25, 2026
Feasibility and Efficacy of Lorlatinib in Japanese Patients With Relapsed/Refractory ALK-Aberrant Neuroblastoma.

|Jul 17, 2026
Personalized reference genome-based pipeline reveals comprehensive haplotype-resolved views of cancer genomes.

|May 29, 2026
Comparative outcomes of umbilical cord blood transplantation versus haploidentical transplantation according to post-transplant cyclophosphamide use in adolescent and young adult patients.

|Apr 29, 2026
Multi-omics analysis of pediatric minimally differentiated acute myeloid leukemia reveals RUNX1-driven stemness and chemoresistance.

|Jan 06, 2026
Combination of oral temozolomide and etoposide as palliative chemotherapy for recurrent or progressive neuroblastoma.

Katsutsugu Umeda, Satoshi Saida, Hirokazu Kobushi

|Nov 02, 2025
Clinical Impact of Immunoglobulin Heavy Chain Clonality in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia.

Yuta Katai, Tatsuya Kamitori, Satoshi Saida

Pageof 7

Frequent Collaborators

27 joint publications

Katsutsugu Umeda

11 joint publications

Hirohito Kubota

10 joint publications

Satoshi Saida

10 joint publications

Junko Takita